India Diabetes Research Foundation and Dr A. Ramachandran's Diabetes Hospitals, Chennai, India.
Diabet Med. 2012 Jan;29(1):94-8. doi: 10.1111/j.1464-5491.2011.03392.x.
The objectives of the study were to assess the predictive value of baseline HbA(1c) for incident diabetes among the participants with impaired glucose tolerance in the Indian Diabetes Prevention Programmes 1 and 2.
Data at baseline and at 3-year follow-up were analysed in combined cohorts of the Indian Diabetes Prevention Programmes 1 and 2. Within the 3 years, 324 of the 845 participants developed diabetes (World Health Organization criteria). The predictive value of baseline HbA(1c) for incident diabetes was determined by logistic regression analysis.
Baseline HbA(1c) values had heterogenous distribution. The distribution was similar in isolated impaired glucose tolerance or in impaired glucose tolerance in combination with impaired fasting glucose. A progressive increase in diabetes occurred with increasing HbA(1c). HbA(1c) showed the strongest association with incident diabetes in the multiple logistic regression analysis (odds ratio 3.548, P < 0.0001). The cut-off HbA(1c) of 43 mmol/mol (6.05%) had 67% sensitivity and 60% specificity to predict future diabetes. The diagnostic sensitivity of HbA(1c) of ≥ 48 mmol/mol (≥ 6.5%) was only 51%, with a specificity of 87%, when compared with the oral glucose tolerance glucose values.
Baseline HbA(1c) was highly predictive of future diabetes in Asian Indian subjects with impaired glucose tolerance and nearly 60% of the incidence occurred with values ≥ 42 mmol/mol (≥ 6.0). Diagnostic sensitivity of HbA(1c) ≥ 48 mmol/mol (≥ 6.5%) for new diabetes was only 51% using the oral glucose tolerance test as the standard for comparison.
本研究旨在评估印度糖尿病预防计划 1 和 2 中葡萄糖耐量受损参与者的基线 HbA(1c) 对新发糖尿病的预测价值。
对印度糖尿病预防计划 1 和 2 的合并队列进行基线和 3 年随访数据分析。在 3 年内,845 名参与者中有 324 名(世界卫生组织标准)发生了糖尿病。采用逻辑回归分析确定基线 HbA(1c) 对新发糖尿病的预测价值。
基线 HbA(1c) 值呈异质分布。在单纯性糖耐量受损或糖耐量受损合并空腹血糖受损中,分布相似。随着 HbA(1c) 的升高,糖尿病的发生率逐渐增加。在多因素逻辑回归分析中,HbA(1c) 与新发糖尿病的相关性最强(比值比 3.548,P<0.0001)。HbA(1c) 为 43mmol/mol(6.05%)的截断值预测未来糖尿病的敏感性为 67%,特异性为 60%。与口服葡萄糖耐量试验相比,HbA(1c)≥48mmol/mol(≥6.5%)的诊断敏感性仅为 51%,特异性为 87%。
基线 HbA(1c) 对亚洲印度裔葡萄糖耐量受损者未来发生糖尿病具有高度预测价值,约 60%的发病率发生在 HbA(1c)≥42mmol/mol(≥6.0)时。使用口服葡萄糖耐量试验作为比较标准,HbA(1c)≥48mmol/mol(≥6.5%)对新发糖尿病的诊断敏感性仅为 51%。